Nadine Wiesmann-Imilowski

Dr. Nadine Wiesmann-Imilowski

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2020 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
NWNadine Wiesmann-Imilowski
Nadine Wiesmann-Imilowski
WTWolfgang Tremel
Wolfgang Tremel
JBJuergen Brieger
Juergen Brieger
The importance of zinc as a trace metal in the human body has long been overlooked. We now gradually discover that the impact of zinc on the health of our body might be as far-reaching as that of iron. Concurrently, nanomaterials containing zinc, in particular zinc oxide nanoparticles (ZnO NPs), are becoming increasingly attractive as innovative agents for medical applications. Zinc oxide is characterized by a good biocompatibility which allows the exploitation of its antibacterial, antifungal, antiviral, and anti-cancer qualities in a therapeutic setting. This perspective outlines the current state of knowledge concerning the interaction of zinc oxide nanoparticles with eukaryotic cells and the human body. Furthermore, it sheds light on the importance of zinc under physiological conditions. This helps to place the in vivo behavior of zinc oxide nanoparticles in the proper context. We evaluate the potential of zinc oxide nanoparticles as innovative anti-tumor agents by summarizing important results of current studies in this field and discuss the proposed mechanisms that give zinc oxide nanoparticles a selective toxicity for tumor cells.

13 October 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
NWNadine Wiesmann-Imilowski
Nadine Wiesmann-Imilowski
SMSimone Mendler
Simone Mendler
CBChristoph R. Buhr
Christoph R. Buhr
URUlrike Ritz
Ulrike Ritz
PKPeer Kämmerer
Peer Kämmerer
JBJuergen Brieger
Juergen Brieger
Due to the demographic change, medicine faces a growing demand for tissue engineering solutions and implants. Often, satisfying tissue regeneration is difficult to achieve especially when co-morbidities hamper the healing process. As a novel strategy, we propose the incorporation of zinc oxide nanoparticles (ZnO NPs) into biomaterials to improve tissue regeneration. Due to their wide range of biocompatibility and their antibacterial properties, ZnO NPs are already discussed for different medical applications. As there are versatile possibilities of modifying their form, size, and function, they are becoming increasingly attractive for tissue engineering. In our study, in addition to antibacterial effects of ZnO NPs, we show for the first time that ZnO NPs can foster the metabolic activity of fibroblasts as well as endothelial cells, both cell types being crucial for successful implant integration. With the gelatin sponge method performed on the chicken embryo’s chorioallantoic membrane (CAM), we furthermore confirmed the high biocompatibility of ZnO NPs. In summary, we found ZnO NPs to have very favorable properties for the modification of biomaterials. Here, incorporation of ZnO NPs could help to guide the tissue reaction and promote complication-free healing.

24 November 2020 in Nanomaterials
Verified
Journal Article
Open access
PDF file
CBChristoph R. Buhr
Christoph R. Buhr
NWNadine Wiesmann-Imilowski
Nadine Wiesmann-Imilowski
Rachel TannerRachel Tanner
Rachel Tanner
JBJuergen Brieger
Juergen Brieger
JEJonas Eckrich
Jonas Eckrich
Nanomaterials unveil many applicational possibilities for technical and medical purposes, which range from imaging techniques to the use as drug carriers. Prior to any human application, analysis of undesired effects and characterization of their toxicological profile is mandatory. To address this topic, animal models, and rodent models in particular, are most frequently used. However, as the reproducibility and transferability to the human organism of animal experimental data is increasingly questioned and the awareness of animal welfare in society increases at the same time, methodological alternatives are urgently required. The chorioallantoic membrane (CAM) assay is an increasingly popular in ovo experimental organism suitable for replacement of rodent experimentation. In this review, we outline several application fields for the CAM assay in the field of nanotoxicology. Furthermore, analytical methods applicable with this model were evaluated in detail. We further discuss ethical, financial, and bureaucratic aspects and benchmark the assay with other established in vivo models such as rodents.

Verified
Journal Article
Open access
PDF file
Diana HeimesDiana Heimes
Diana Heimes
NWNadine Wiesmann-Imilowski
Nadine Wiesmann-Imilowski
JEJonas Eckrich
Jonas Eckrich
JBJuergen Brieger
Juergen Brieger
SMStefan Mattyasovszkya
Stefan Mattyasovszkya
PKPeer Kämmerer
Peer Kämmerer
The effective management of tissue integration and immunological responses to transplants decisively co-determines the success of soft and hard tissue reconstruction. The aim of this in vivo study was to evaluate the eligibility of extracorporeal shock wave therapy (ESWT) with respect to its ability to modulate angiogenesis and immune response to a collagen matrix (CM) for tissue engineering in the chorioallantoic membrane (CAM) assay, which is performed with fertilized chicken eggs. CM were placed on the CAM on embryonic development day (EDD) 7; at EDD-10, ESWT was conducted at 0.12 mJ/mm2 with 500 impulses each. One and four days later, angiogenesis represented by vascularized area, vessel density, and vessel junctions as well as HIF-1α and VEGF gene expression were evaluated. Furthermore, immune response (iNOS2, MMP-9, and MMP-13 via qPCR) was assessed and compared between ESWT- and non-ESWT-groups. At EDD-14, the vascularized area (+115% vs. +26%) and the increase in vessel junctions (+751% vs. +363%) were significantly higher in the ESWT-group. ESWT significantly increased MMP-9 gene expression at EDD-11 and significantly decreased MMP-13 gene expression at EDD-14 as compared to the controls. Using the CAM assay, an enhanced angiogenesis and neovascularization in CM after ESWT were observed. Furthermore, ESWT could reduce the inflammatory activity after a latency of four days.

Verified
Journal Article
Open access
PDF file
LMLena Katharina Müller-Heupt
Lena Katharina Müller-Heupt
NWNadine Wiesmann-Imilowski
Nadine Wiesmann-Imilowski
SKSebahat Kaya
Sebahat Kaya
SSSven Schumann
Sven Schumann
MSMaximilian Steiger
Maximilian Steiger
KLKarl Martin Lehmann
Karl Martin Lehmann
(1) This study investigated the whitening effect, cytotoxicity and enamel surface alterations induced by different over-the-counter (OTC) bleaching agents in comparison to hydrogen peroxide. (2) Human teeth (n = 60) were randomly assigned into 6 groups (n = 10), stained with coffee solution for 7 d, followed by a whitening period of 7 d with either placebo, bromelain, sodium bicarbonate, sodium chlorite, PAP or hydrogen peroxide. Color measurements were performed with a spectrophotometer. Scanning electron micrographs (SEM) were taken to assess the enamel structure. Cytotoxicity of the tested substances was assessed based on the cell viability of primary human fibroblasts. (3) The application of all whitening gels resulted in a greater color difference of the enamel (ΔE) in comparison to the negative control. Hydrogen peroxide caused the greatest color difference. Bromelain and PAP treatment showed no enamel surface changes, in contrast to hydrogen peroxide treatment, which showed very mild interprismatic dissolution. Bromelain was the only non-cytotoxic agent. (4) The maximum effect achieved by all OTC bleaching agents was the removal of stains, whereas hydrogen peroxide was capable of further whitening the teeth. Bromelain treatment was neither cytotoxic, nor resulted in enamel surface alterations, and its whitening effect was less, yet still effective, compared to hydrogen peroxide.

1 December 2020 in Toxicology in Vitro
Verified
Journal Article
Closed access
MVM.F. Vermehren
M.F. Vermehren
NWNadine Wiesmann-Imilowski
Nadine Wiesmann-Imilowski
JDJ. Deschner
J. Deschner
JBJ. Brieger
J. Brieger
BAB. Al-Nawas
B. Al-Nawas
PKP.W. Kämmerer
P.W. Kämmerer